BioCorRx

BioCorRx has the worldwide rights (except in Australia and New Zealand) to a highly effective, proprietary implant compound of the FDA-approved drug naltrexone. After being surgically implanted by a medical professional, the naltrexone implant significantly reduces cravings for alcohol and opiates for as long as a year in some patients, depending on individual metabolism rates and other factors. Furthermore, once the implant has dissolved, a vast majority of patients are pleased to discover that their physical cravings for alcohol continue to remain greatly reduced or even eliminated.

BioCorRx also owns a life-coaching program that is tailored specifically to substance abuse addicts. Once a patient has received the implant, they are encouraged to enter the life-coaching program to maximize results.

BioCorRx’s revolutionary Start Fresh Program has an 85% success rate as reported by patients in routine telephone and face-to-face interviews conducted by the independently owned and operated clinics using the SFP. The implant is administered as an outpatient procedure, and in most cases, patients do not need to miss more than one day of work. They are then able to enter the private life-coaching program without co-workers or family members knowing, unless they so choose.

Read More